🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Sage Therapeutics, Inc.

Sage Therapeutics, Inc. logo
Market Cap: Medium
Employees: Medium

ZULRESSO

Sage Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes medicines for central nervous system disorders, with ZULRESSO for postpartum depression and a pipeline including zuranolone and SAGE-324 for various mood and neurological disorders.

Tags: biopharmaceutical, central nervous system disorders, clinical trials, postpartum depression

Symbol: SAGE

Recent Price: $5.43

Industry: Biotechnology

CEO: Mr. Barry E. Greene

Sector: Healthcare

Employees: 487

Address: 215 First Street, Cambridge, MA 02142

Phone: 617 299 8380

Leadership

  • BARRY GREENE, Member of Board of Directors
  • CHRIS BENECCHI, Chief Business Officer
  • ANNE MARIE COOK, Senior Vice President, General Counsel
  • LAURA GAULT, M.D., Ph.D., Chief Medical Officer
  • PAMELA HERBSTER, Vice President, Head of People
  • KIMI IGUCHI, Chief Financial Officer
  • MATT LASMANIS, Chief Technology and Innovation Officer
  • MIKE QUIRK, Ph.D., Chief Scientific Officer
  • VANESSA PROCTER, Senior Vice President, External Affairs
  • AMY SCHACTERLE, Ph.D., Senior Vice President, R&D Strategy and Business Management
  • HEINRICH SCHLIEKER, Ph.D., Senior Vice President, Technical Operations
  • LIZ BARRETT, President & Chief Executive Officer
  • MICHAEL F. COLA,
  • JESSICA FEDERER,
  • JAMES M. FRATES,
  • GENO GERMANO, CHAIR OF THE BOARD
  • GEORGE GOLUMBESKI, Ph.D.,
  • JEFF JONAS, M.D.,

Last updated: 2024-12-31